Investigational Site Number : 5780101

Oslo 0450

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm Malignant

Studies at this site

• First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL — Completed